Jack r. Bennink

Q: What Schools Are Affiliated With Jack r. Bennink

Jack r. Bennink is affiliated with the following schools: Pennsylvania State University, Osaka University, University of Würzburg, New York University, Thomas Jefferson University

Jack r. Bennink's AcademicInfluence.com Rankings

Jack r. Bennink

Biology

#9550

World Rank

#12767

Historical Rank

Molecular Biology

#1323

World Rank

#1350

Historical Rank

Biochemistry

#1470

World Rank

#1596

Historical Rank

biology Degrees

Download Badge

Biology

Jack r. Bennink's Degrees

PhD Biochemistry Stanford University
Bachelors Chemistry University of California, Berkeley

Why Is Jack r. Bennink Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Jack r. Bennink's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Rapid degradation of a large fraction of newly synthesized proteins by proteasomes (2000) (1594)
A novel influenza A virus mitochondrial protein that induces cell death (2001) (1040)
Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses. (1999) (1039)
CD1 recognition by mouse NK1+ T lymphocytes. (1995) (958)
Localization, quantitation, and in situ detection of specific peptide-MHC class I complexes using a monoclonal antibody. (1997) (775)
Identification of human cancers deficient in antigen processing (1993) (657)
Influenza A virus nucleoprotein is a major target antigen for cross-reactive anti-influenza A virus cytotoxic T lymphocytes. (1985) (524)
Quantitating protein synthesis, degradation, and endogenous antigen processing. (2003) (523)
Defective ribosomal products (DRiPs): a major source of antigenic peptides for MHC class I molecules? (1996) (466)
Natural ligand of mouse CD1d1: cellular glycosylphosphatidylinositol. (1998) (440)
Hemagglutinin Receptor Binding Avidity Drives Influenza A Virus Antigenic Drift (2009) (440)
Expression of the 1918 influenza A virus PB1-F2 enhances the pathogenesis of viral and secondary bacterial pneumonia. (2007) (401)
Visualizing priming of virus-specific CD8+ T cells by infected dendritic cells in vivo (2002) (377)
Cell biology of antigen processing and presentation to major histocompatibility complex class I molecule-restricted T lymphocytes. (1992) (376)
Dissecting the multifactorial causes of immunodominance in class I-restricted T cell responses to viruses. (2000) (364)
Proteasome inhibition interferes with gag polyprotein processing, release, and maturation of HIV-1 and HIV-2. (2000) (349)
Identification of poxvirus CD8+ T cell determinants to enable rational design and characterization of smallpox vaccines (2005) (349)
CD8+ T Cell Cross-Priming via Transfer of Proteasome Substrates (2004) (332)
Mechanisms of exogenous antigen presentation by MHC class I molecules in vitro and in vivo: implications for generating CD8+ T cell responses to infectious agents, tumors, transplants, and vaccines. (1999) (328)
Brefeldin A specifically inhibits presentation of protein antigens to cytotoxic T lymphocytes. (1989) (313)
Generation of both cross-reactive and virus-specific T-cell populations after immunization with serologically distinct influenza A viruses (1977) (307)
Immunoproteasomes Shape Immunodominance Hierarchies of Antiviral Cd8+ T Cells at the Levels of T Cell Repertoire and Presentation of Viral Antigens (2001) (301)
A recombinant vector derived from the host range-restricted and highly attenuated MVA strain of vaccinia virus stimulates protective immunity in mice to influenza virus. (1994) (300)
Innate Immune and Chemically Triggered Oxidative Stress Modifies Translational Fidelity (2009) (297)
CD4 Glycoprotein Degradation Induced by Human Immunodeficiency Virus Type 1 Vpu Protein Requires the Function of Proteasomes and the Ubiquitin-Conjugating Pathway (1998) (284)
Antigen processing in vivo and the elicitation of primary CTL responses. (1995) (257)
Cross-Reactivity between Hepatitis C Virus and Influenza A Virus Determinant-Specific Cytotoxic T Cells (2001) (244)
Cutting edge: adenovirus E19 has two mechanisms for affecting class I MHC expression. (1999) (241)
Nuclear translation visualized by ribosome-bound nascent chain puromycylation (2012) (240)
MHC affinity, peptide liberation, T cell repertoire, and immunodominance all contribute to the paucity of MHC class I-restricted peptides recognized by antiviral CTL. (1997) (238)
Direct priming of antiviral CD8+ T cells in the peripheral interfollicular region of lymph nodes (2008) (237)
The Influenza A Virus PB1-F2 Protein Targets the Inner Mitochondrial Membrane via a Predicted Basic Amphipathic Helix That Disrupts Mitochondrial Function (2003) (235)
Intracellular Localization of Proteasomal Degradation of a Viral Antigen (1999) (231)
The binary logic of antigen processing and presentation to T cells (1990) (226)
Cells process exogenous proteins for recognition by cytotoxic T lymphocytes. (1988) (216)
Recombinant vaccinia virus primes and stimulates influenza haemagglutinin-specific cytotoxic T cells (1984) (212)
The Human Immunodeficiency Virus Type 1 (HIV-1) Vpu Protein Interferes with an Early Step in the Biosynthesis of Major Histocompatibility Complex (MHC) Class I Molecules (1997) (204)
Flanking sequences influence the presentation of an endogenously synthesized peptide to cytotoxic T lymphocytes (1992) (199)
Heterosubtypic immunity to influenza A virus: where do we stand? (2008) (198)
Mechanism of protective immunity against influenza virus infection in mice without antibodies. (1998) (197)
Trimming of antigenic peptides in an early secretory compartment (1994) (193)
TAP-independent, beta 2-microglobulin-dependent surface expression of functional mouse CD1.1 (1995) (183)
Antigen presentation requires transport of MHC class I molecules from the endoplasmic reticulum. (1990) (178)
TAP (transporter associated with antigen processing)-independent presentation of endogenously synthesized peptides is enhanced by endoplasmic reticulum insertion sequences located at the amino- but not carboxyl-terminus of the peptide. (1994) (172)
Cytotoxic T-cell responses in mice infected with influenza and vaccinia viruses vary in magnitude with H-2 genotype (1978) (168)
Expression of a membrane protease enhances presentation of endogenous antigens to MHC class I-restricted T lymphocytes (1992) (168)
Regulatory T Cells Suppress CD8+ T Cell Responses Induced by Direct Priming and Cross-Priming and Moderate Immunodominance Disparities (2005) (159)
HLA class I-restricted responses to vaccinia recognize a broad array of proteins mainly involved in virulence and viral gene regulation. (2005) (157)
CXCR3 chemokine receptor enables local CD8(+) T cell migration for the destruction of virus-infected cells. (2015) (156)
Most Influenza A Virions Fail To Express at Least One Essential Viral Protein (2013) (147)
Invariant chain targets HLA class II molecules to acidic endosomes containing internalized influenza virus. (1991) (144)
Host range restricted, non-replicating vaccinia virus vectors as vaccine candidates. (1996) (141)
RMA/S cells present endogenously synthesized cytosolic proteins to class I-restricted cytotoxic T lymphocytes (1992) (133)
Poxvirus CD8+ T-Cell Determinants and Cross-Reactivity in BALB/c Mice (2006) (130)
Nuclear localization of a double-stranded RNA-binding protein encoded by the vaccinia virus E3L gene. (1993) (129)
Characterization of Rapidly Degraded Polypeptides in Mammalian Cells Reveals a Novel Layer of Nascent Protein Quality Control* (2006) (129)
Fitness costs limit influenza A virus hemagglutinin glycosylation as an immune evasion strategy (2011) (129)
Defective presentation of endogenous antigens by a murine sarcoma. Implications for the failure of an anti-tumor immune response. (1991) (129)
The generation of MHC class I-associated peptides is only partially inhibited by proteasome inhibitors: involvement of nonproteasomal cytosolic proteases in antigen processing? (1997) (126)
Cut and trim: generating MHC class I peptide ligands. (2001) (126)
Anti-influenza virus cytotoxic T lymphocytes recognize the three viral polymerases and a nonstructural protein: responsiveness to individual viral antigens is major histocompatibility complex controlled (1987) (126)
Recognition of cloned vesicular stomatitis virus internal and external gene products by cytotoxic T lymphocytes (1986) (124)
Multiple Paths for Activation of Naive CD8+ T Cells: CD4-Independent Help1 (2001) (123)
Recycling CD1d1 Molecules Present Endogenous Antigens Processed in an Endocytic Compartment to NKT Cells1 (2002) (123)
MHC class I-associated peptides produced from endogenous gene products with vastly different efficiencies. (1997) (121)
Modification of Cysteine Residues In Vitro and In Vivo Affects the Immunogenicity and Antigenicity of Major Histocompatibility Complex Class I–restricted Viral Determinants (1999) (121)
Influenza and vaccinia viruses expressing malaria CD8+ T and B cell epitopes. Comparison of their immunogenicity and capacity to induce protective immunity. (1994) (120)
Retention of adenovirus E19 glycoprotein in the endoplasmic reticulum is essential to its ability to block antigen presentation (1991) (118)
A viral polymerase involved in recognition of influenza virus-infected cells by a cytotoxic T-cell clone (1982) (116)
Cytotoxic T cells specific for a single peptide on the M2 protein of respiratory syncytial virus are the sole mediators of resistance induced by immunization with M2 encoded by a recombinant vaccinia virus (1995) (113)
Direct delivery of exogenous MHC class I molecule-binding oligopeptides to the endoplasmic reticulum of viable cells. (1997) (110)
Mechanisms of viral interference with MHC class I antigen processing and presentation. (1999) (110)
Multiple Antigen-Specific Processing Pathways for Activating Naive CD8+ T Cells In Vivo (2001) (108)
Cutting Edge: Sympathetic Nervous System Increases Proinflammatory Cytokines and Exacerbates Influenza A Virus Pathogenesis (2009) (106)
At the crossroads of cell biology and immunology: DRiPs and other sources of peptide ligands for MHC class I molecules. (2001) (102)
Cross‐priming of CD8+ T cells by viral and tumor antigens is a robust phenomenon (2004) (102)
Effect of TAP on the generation and intracellular trafficking of peptide-receptive major histocompatibility complex class I molecules. (1995) (102)
Two Novel Routes of Transporter Associated with Antigen Processing (TAP)-independent Major Histocompatibility Complex Class I Antigen Processing (1997) (101)
Glycosylation Focuses Sequence Variation in the Influenza A Virus H1 Hemagglutinin Globular Domain (2010) (101)
MHC-encoded proteasome subunits LMP2 and LMP7 are not required for efficient antigen presentation. (1994) (100)
Assembly, Intracellular Localization, and Nucleotide Binding Properties of the Human Peptide Transporters TAP1 and TAP2 Expressed by Recombinant Vaccinia Viruses (*) (1995) (96)
Unexpected Role for the Immunoproteasome Subunit LMP2 in Antiviral Humoral and Innate Immune Responses (2010) (96)
An Endoplasmic Reticulum-Targeting Signal Sequence Enhances the Immunogenicity of an Immunorecessive Simian Virus 40 Large T Antigen Cytotoxic T-Lymphocyte Epitope (1998) (92)
Cells adapted to the proteasome inhibitor 4-hydroxy- 5-iodo-3-nitrophenylacetyl-Leu-Leu-leucinal-vinyl sulfone require enzymatically active proteasomes for continued survival. (2001) (92)
Defining influenza A virus hemagglutinin antigenic drift by sequential monoclonal antibody selection. (2013) (92)
Immunization of mice with vaccinia virus-M2 recombinant induces epitope-specific and cross-reactive Kd-restricted CD8+ cytotoxic T cells (1993) (89)
Sympathetic nervous system control of anti-influenza CD8+ T cell responses (2009) (88)
Recombinant vaccinia viruses as vectors for studying T lymphocyte specificity and function. (1990) (87)
Viral infection triggers rapid differentiation of human blood monocytes into dendritic cells. (2012) (87)
Reversal in the Immunodominance Hierarchy in Secondary CD8+ T Cell Responses to Influenza A Virus: Roles for Cross-Presentation and Lysis-Independent Immunodomination1 (2004) (86)
Primary pulmonary cytotoxic T lymphocytes induced by immunization with a vaccinia virus recombinant expressing influenza A virus nucleoprotein peptide do not protect mice against challenge (1994) (86)
Chemokines control naive CD8+ T cell selection of optimal lymph node antigen presenting cells (2011) (83)
A survival game of hide and seek: cytomegaloviruses and MHC class I antigen presentation pathways. (2003) (82)
Tight Linkage between Translation and MHC Class I Peptide Ligand Generation Implies Specialized Antigen Processing for Defective Ribosomal Products1 (2006) (82)
Murine cytotoxic T lymphocyte recognition of individual influenza virus proteins. High frequency of nonresponder MHC class I alleles (1988) (82)
Introduction of a Glycosylation Site into a Secreted Protein Provides Evidence for an Alternative Antigen Processing Pathway: Transport of Precursors of Major Histocompatability Complex Class I–Restricted Peptides from the Endoplasmic Reticulum to the Cytosol (1997) (82)
Recognition of cloned influenza virus hemagglutinin gene products by cytotoxic T lymphocytes (1986) (78)
Vaccination with DNA encoding internal proteins of influenza virus does not require CD8(+) cytotoxic T lymphocytes: either CD4(+) or CD8(+) T cells can promote survival and recovery after challenge. (2000) (78)
Human Cytomegalovirus Protein US2 Interferes with the Expression of Human HFE, a Nonclassical Class I Major Histocompatibility Complex Molecule That Regulates Iron Homeostasis (2001) (76)
RNA Binding Targets Aminoacyl-tRNA Synthetases to Translating Ribosomes* (2011) (76)
Quantitating T Cell Cross-Reactivity for Unrelated Peptide Antigens1 (2009) (76)
HLA-A*0201, HLA-A*1101, and HLA-B*0702 transgenic mice recognize numerous poxvirus determinants from a wide variety of viral gene products. (2005) (74)
Dissociation of proteasomal degradation of biosynthesized viral proteins from generation of MHC class I-associated antigenic peptides. (1998) (72)
Influenza A Virus Hemagglutinin Antibody Escape Promotes Neuraminidase Antigenic Variation and Drug Resistance (2011) (71)
Generating MHC class I ligands from viral gene products (1999) (71)
The exception that reinforces the rule: crosspriming by cytosolic peptides that escape degradation. (2008) (71)
Compartmentalized MHC class I antigen processing enhances immunosurveillance by circumventing the law of mass action (2010) (69)
Mice Deficient in Perforin, CD4+ T Cells, or CD28-Mediated Signaling Maintain the Typical Immunodominance Hierarchies of CD8+ T-Cell Responses to Influenza Virus (2002) (69)
Cutting Edge: Recombinant Adenoviruses Induce CD8 T Cell Responses to an Inserted Protein Whose Expression Is Limited to Nonimmune Cells (2001) (68)
Presentation of endogenous and exogenous antigens is not affected by inactivation of E1 ubiquitin-activating enzyme in temperature-sensitive cell lines. (1995) (68)
Inhibitory Effects of Cytomegalovirus Proteins US2 and US11 Point to Contributions from Direct Priming and Cross-Priming in Induction of Vaccinia Virus-Specific CD8+ T Cells (2002) (68)
Anatomically restricted synergistic antiviral activities of innate and adaptive immune cells in the skin. (2013) (67)
Monitoring cotranslational protein folding in mammalian cells at codon resolution (2012) (67)
HLA-A*0201, HLA-A*1101, and HLA-B*0702 Transgenic Mice Recognize Numerous Poxvirus Determinants from a Wide Variety of Viral Gene Products1 (2005) (67)
Fusion Proteins with COOH-terminal Ubiquitin Are Stable and Maintain Dual Functionality in Vivo * (2002) (65)
Endogenous viral antigen processing generates peptide-specific MHC class I cell-surface clusters (2012) (65)
Promiscuous liberation of MHC‐class I‐binding peptides from the C termini of membrane and soluble proteins in the secretory pathway (1998) (64)
Reassortment Complements Spontaneous Mutation in Influenza A Virus NP and M1 Genes To Accelerate Adaptation to a New Host (2013) (63)
Translating DRiPs: progress in understanding viral and cellular sources of MHC class I peptide ligands (2011) (62)
Discovering naturally processed antigenic determinants that confer protective T cell immunity. (2013) (61)
Influenza A virus nucleoprotein selectively decreases neuraminidase gene-segment packaging while enhancing viral fitness and transmissibility (2014) (61)
Lamprey VLRB response to influenza virus supports universal rules of immunogenicity and antigenicity (2015) (57)
Distinct Pathways Generate Peptides from Defective Ribosomal Products for CD8+ T Cell Immunosurveillance (2011) (56)
mTORC1 Links Protein Quality and Quantity Control by Sensing Chaperone Availability*♦ (2010) (55)
Fluorescent conjugates of brefeldin A selectively stain the endoplasmic reticulum and Golgi complex of living cells. (1995) (51)
PD-1 Blockade Promotes Epitope Spreading in Anticancer CD8+ T Cell Responses by Preventing Fratricidal Death of Subdominant Clones To Relieve Immunodomination (2017) (50)
Cutting Edge: MHC Class I–Ly49 Interaction Regulates Neuronal Function (2008) (46)
Defective Ribosomal Products Are the Major Source of Antigenic Peptides Endogenously Generated from Influenza A Virus Neuraminidase (2009) (46)
Viral Alteration of Cellular Translational Machinery Increases Defective Ribosomal Products (2007) (44)
Influenza basic polymerase 2 peptides are recognized by influenza nucleoprotein-specific cytotoxic T lymphocytes. (1992) (44)
T-cell populations specifically depleted of alloreactive potential cannot be induced to lyse H-2-different virus-infected target cells (1978) (41)
Strategies for tumor elimination by cytotoxic T lymphocytes. (1998) (41)
Vaccinia and influenza A viruses select rather than adjust tRNAs to optimize translation (2012) (39)
Detection of shared MHC-restricted human melanoma antigens after vaccinia virus-mediated transduction of genes coding for HLA. (1993) (38)
RNA Polymerase II Inhibitors Dissociate Antigenic Peptide Generation from Normal Viral Protein Synthesis: A Role for Nuclear Translation in Defective Ribosomal Product Synthesis? (2010) (38)
MHC class I antigen processing distinguishes endogenous antigens based on their translation from cellular vs. viral mRNA (2012) (36)
CTL recognition of adenovirus-transformed cells infected with influenza virus: lysis by anti-influenza CTL parallels adenovirus-12-induced suppression of class I MHC molecules. (1988) (36)
Recognition of noninfectious influenza virus by class I-restricted murine cytotoxic T lymphocytes. (1988) (35)
Calnexin expression does not enhance the generation of MHC class I‐peptide complexes (1998) (34)
Caught in the act: intravital multiphoton microscopy of host-pathogen interactions. (2009) (34)
The promise of siRNAs for the treatment of influenza. (2004) (33)
Quantitating defective ribosome products. (2005) (33)
Class II MHC-restricted T cell determinants processed from either endosomes or the cytosol show similar requirements for host protein transport but different kinetics of presentation. (1991) (32)
A Simple Flow-Cytometric Method Measuring B Cell Surface Immunoglobulin Avidity Enables Characterization of Affinity Maturation to Influenza A Virus (2015) (32)
Immune responses to viruses. (2009) (32)
Influenza A Virus Hemagglutinin Trimerization Completes Monomer Folding and Antigenicity (2013) (31)
Class I molecules retained in the endoplasmic reticulum bind antigenic peptides (1993) (31)
Presentation of numerous viral peptides to mouse major histocompatibility complex (MHC) class I-restricted T lymphocytes is mediated by the human MHC-encoded transporter or by a hybrid mouse- human transporter (1993) (30)
Emetine optimally facilitates nascent chain puromycylation and potentiates the ribopuromycylation method (RPM) applied to inert cells (2013) (29)
Heat-Aggregated Noninfectious Influenza Virus Induces a More Balanced CD8+-T-Lymphocyte Immunodominance Hierarchy Than Infectious Virus (2003) (27)
Murine Norovirus Infection Has No Significant Effect on Adaptive Immunity to Vaccinia Virus or Influenza A Virus (2009) (26)
Influenza virus hemagglutinin trimers and monomers maintain distinct biochemical modifications and intracellular distribution in brefeldin A-treated cells. (1991) (25)
Mild acid treatment induces cross-reactivity of 4H84 monoclonal antibody specific to nonclassical HLA-G antigen with classical HLA class I molecules. (2003) (24)
Locally Produced IL-10 Limits Cutaneous Vaccinia Virus Spread (2016) (23)
The export of major histocompatibility complex class I molecules from the endoplasmic reticulum of rat brown adipose cells is acutely stimulated by insulin. (2001) (22)
Assembly of MHC class I molecules with biosynthesized endoplasmic reticulum-targeted peptides is inefficient in insect cells and can be enhanced by protease inhibitors. (1998) (22)
Terminal Deoxynucleotidyl Transferase Establishes and Broadens Antiviral CD8+ T Cell Immunodominance Hierarchies1 (2008) (22)
Murine cell lines stably expressing the influenza virus hemagglutinin gene introduced by a recombinant retrovirus vector are constitutive targets for MHC class I- and class II-restricted T lymphocytes. (1989) (22)
Antigen processing: where tumor-specific T-cell responses begin. (1993) (20)
Defining Viral Defective Ribosomal Products: Standard and Alternative Translation Initiation Events Generate a Common Peptide from Influenza A Virus M2 and M1 mRNAs (2016) (20)
Restricting Expression Prolongs Expression of Foreign Genes Introduced into Animals by Retroviruses (2000) (20)
An Examination of MHC Restriction in the Context of a Minimal Clonal Abortion Model for Tolerance (1980) (20)
The TL MHC class Ib molecule has only marginal effects on the activation, survival and trafficking of mouse small intestinal intraepithelial lymphocytes. (2004) (19)
CD8αα-Mediated Intraepithelial Lymphocyte Snatching of Thymic Leukemia MHC Class Ib Molecules In Vitro and In Vivo1 (2006) (19)
Efficient Cross-Priming of Antiviral CD8+ T Cells by Antigen Donor Cells Is GRP94 Independent1 (2009) (19)
A transient transfection system for identifying biosynthesized proteins processed and presented to class I MHC restricted T lymphocytes (1992) (18)
Expression of adenovirus E3/19K protein does not alter mouse MHC class I-restricted responses to vaccinia virus. (1994) (17)
Target and effector cell fusion accounts for B lymphocyte-mediated lysis of mouse hepatitis virus-infected cells. (1989) (17)
Influenza virus-induced encephalopathy in mice: interferon production and natural killer cell activity during acute infection (1986) (16)
Reciprocal stimulation of negatively selected high-responder and low-responder T cells in virus-infected recipients. (1979) (16)
Influenza A Virus Infection Induces Viral and Cellular Defective Ribosomal Products Encoded by Alternative Reading Frames (2019) (16)
The response to H-2-different virus-infected cells is mediated by long-lived T lymphocytes and is diminished by prior virus priming in a syngeneic environment. (1981) (15)
Limiting dilution analysis of memory cytotoxic T lymphocytes specific for individual influenza virus gene products. (1988) (14)
Ubiquitous Autofragmentation of Fluorescent Proteins Creates Abundant Defective Ribosomal Products (DRiPs) for Immunosurveillance* (2015) (14)
Systematic search fails to detect immunogenic MHC class-I-restricted determinants encoded by influenza A virus noncoding sequences. (2003) (13)
CD8 alpha alpha-mediated intraepithelial lymphocyte snatching of thymic leukemia MHC class Ib molecules in vitro and in vivo. (2006) (13)
Early dominance of irradiated host cells in the responder profiles of thymocytes from P leads to F1 radiation chimeras. (1981) (12)
Identification of overlapping class I and class II H-2d-restricted T cell determinants of influenza virus N1 neuraminidase that require infectious virus for presentation. (1994) (12)
Biogenesis of Influenza A Virus Hemagglutinin Cross-Protective Stem Epitopes (2014) (11)
[24] Collection of mouse thoracic duct lymphocytes (1984) (11)
Negative selection experiments support the idea that T-T help is required for the H-Y specific cytotoxic T cell response. (1981) (11)
P-glycoprotein plays an insignificant role in the presentation of antigenic peptides to CD8+ T cells. (1998) (11)
Structure of the N-linked oligosaccharides of MHC class I molecules from cells deficient in the antigenic peptide transporter. Implications for the site of peptide association. (1995) (10)
Chronic Ethanol Ingestion in Rats Decreases Granulocyte-Macrophage Colony-Stimulating Factor Receptor Expression and Downstream Signaling in the Alveolar Macrophage (2005) (9)
Bacterial Superantigens Expand and Activate, Rather than Delete or Incapacitate, Preexisting Antigen-Specific Memory CD8+ T Cells (2018) (9)
The multiple uses of viruses for studying antigen processing (1993) (8)
From optical bench to cageside: intravital microscopy on the long road to rational vaccine design (2011) (8)
T cells that encounter virus in the complete absence of a particular H- 2 antigen are nonresponsive when stimulated again in the context of that H-2 antigen (1980) (8)
Use of recombinant vaccinia viruses to examine cytotoxic T lymphocyte recognition of individual viral proteins. (1988) (7)
Quantitating presentation of MHC class I-restricted antigens. (2001) (6)
Sympathetic nervous system control of anti-influenza CD 8 T cell responses (2009) (6)
Monitoring the integrity of self: biology of MHC-restriction of virus-immune T cells. (1981) (6)
Thymocytes can be stimulated to give a strong vaccinia virus-immune cytotoxic T lymphocyte response. (1981) (6)
Primary pulmonary murine cytotoxic T lymphocyte specificity in respiratory syncytial virus pneumonia. (1990) (6)
Antigen processing: a critical factor in rational vaccine design. (1993) (6)
IDENTIFICATION OF HUMAN CANCERS DEFECTIVE IN ANTIGEN PROCESSING (1993) (5)
Collection of mouse thoracic duct lymphocytes. (1984) (5)
Negatively selected H-2bml and H-2b cells stimulated with vaccinia virus completely discriminate between mutant and wild-type H-2K alleles. (1981) (5)
Expression Mechanisms for Affecting Class I MHC Cutting Edge : Adenovirus E 19 Has Two and (1999) (4)
Cross-reactivity patterns of influenza-specific cytotoxic T lymphocytes from H-2Kb mutant mice. (1983) (3)
Cutting Edge: Sympathetic nervous system increases proinflammatory cytokines and exacerbates influenza A virus pathogenesis (2010) (3)
Use of proteasome inhibitors to examine processing of antigens for major histocompatibility complex class I presentation. (2001) (3)
Cysteinyl-tRNA Deacylation Can Be Uncoupled from Protein Synthesis (2012) (3)
A monoclonal antibody to an interspecies major histocompatibility determinant inhibits a virus-specific T-cell clone. (1982) (3)
Virus-immune cytotoxic T-cell activity following negative selection of alloreactive precursor lymphocytes. (1980) (3)
Processing and presentation of antigens to class I restricted T lymphocytes. (1989) (3)
Author response: Lamprey VLRB response to influenza virus supports universal rules of immunogenicity and antigenicity (2015) (3)
CD8 T Cell Cross-Priming via Transfer of (2004) (3)
Discordant rearrangement of primary and anamnestic CD8+ T cell responses to influenza A viral epitopes upon exposure to bacterial superantigens: Implications for prophylactic vaccination, heterosubtypic immunity and superinfections (2020) (3)
The Dual Specificity of Virus-Immune T Cells (1981) (2)
Spontaneous mutation at position 114 in H‐2Kd affects cytotoxic T cell responses to influenza virus infection (1999) (2)
Current Trends in Histocompatibility (1981) (2)
CXCR 3 Chemokine Recep tor Enables Local CD 8 + T Cell Migration for the Destruction of Virus-Infected Cells Highlights (2015) (2)
Factors influencing the vaccinia-specific cytotoxic response of thymocytes from normal and chimeric mice. (1981) (2)
Most Influenza A Virions Fail to Express At Least One Essential 1 Viral Protein 2 3 Running title : Incomplete viral protein expression by IAV virions (2013) (1)
Vaccination with DNA encoding conserved influenza viral proteins (2001) (1)
MHC Class I-Associated Antigenic Peptides Biosynthesized Viral Proteins from Generation of Dissociation of Proteasomal Degradation of (1998) (1)
Overview of the Viral Pathogens (2002) (1)
A novel vaccine approach to stimulate class I restricted T cells. (2000) (1)
Erratum: HLA-A*0201, HLA-A*1101, and HLA-B*0702 transgenic mice recognize numerous poxvirus determinants from a wide variety of viral gene products (Journal of Immunology (2005) 175 (5504-5515)) (2005) (1)
This information is current as Clones To Relieve Immunodomination SubdominantPreventing Fratricidal Death of T Cell Responses by + in Anticancer CD 8 PD-1 Blockade Promotes Epitope Spreading (2017) (1)
T Cells : CD 4-Independent Help + Multiple Paths for Activation of Naive CD 8 Frelinger (2001) (0)
Slowing Influenza Virus Evolution: A Role for Multiple Synergistic Antiviral Specificities in Vaccination Strategies (2020) (0)
Enhanced presentation by MHC class I of an influenza nucleoprotein epitope in the presence of proteasome inhibitors (1997) (0)
, The signal sequence peptide of the endoplasmic reticulum, and peptide-encode at least one other, their use in vaccines and to treat diseases (1994) (0)
Influenza A Virus Hemagglutinin Trimerization Completes 1 Monomer Folding and Antigenicity 2 3 (2013) (0)
Specialized Antigen Processing for Defective Class I Peptide Ligand Generation Implies Tight Linkage between Translation and MHC (2006) (0)
The RiboPuroMycylation method reveals surprising protein synthesis in bone marrow T cells within a day of vaccinia virus infection (P3385) (2013) (0)
Blockade of MHC Class I Molecule Transport from the Endoplasmic Reticulum Inhibits Presentation of Protein Antigens to Cytotoxic T Lymphocytes (1989) (0)
Most Influenza A Virions Fail To Express at Least One Essential Viral Protein (2013) (0)
Frontiers in viral immunology: sympathetic nervous system control of anti-influenza immunity. (2008) (0)
Cdc2/Cyclin B1 Interacts with and Modulates Inositol 1,4,5-Trisphosphate Receptor (Type 1) Functions (2005) (0)
Immunosurveillance T + Defective Ribosomal Products for CD 8 Distinct Pathways Generate Peptides from (2011) (0)
This information is current as In Vivo T Cells + Pathways for Activating Naive CD 8 Multiple Antigen-Specific Processing (2001) (0)
Peptide from Influenza A Virus M 2 and M 1 Initiation Events Generate a Common Standard and Alternative Translation Defining Viral Defective Ribosomal Products : (2016) (0)
MECHANISMS OF VIRAL INTERFERENCE WITH MHC CLASS IA NTIGEN PROCESSING (1999) (0)
Overview of Viral Pathogens (2011) (0)
Protease Inhibitors Insect Cells and Can Be Enhanced by Reticulum-Targeted Peptides Is Inefficient in Biosynthesized Endoplasmic Assembly of MHC Class I Molecules with Cresswell (1998) (0)
The RiboPuromycylation Method Reveals Rapid IL12-Dependent Antigen-Independent Activation of Bone Marrow Virtual Memory T cells (INC1P.403) (2015) (0)
Editorial Board (2016) (0)
Will wonders never cease? Unraveling the Intricacies of the class I processing pathway (2012) (0)
Naturally processed HLA class I-restricted epitopes inform targets of protective CD8+ T cell-mediated immunity (113.11) (2012) (0)
Career lasting influences. (2014) (0)
Cross-Priming and Moderate Responses Induced by Direct Priming and Regulatory T Cells Suppress CD8+ T Cell (2013) (0)
Is GRP94 Independent T Cells by Antigen Donor Cells + CD8Cross-Priming of Antiviral (2009) (0)
196. Nicotinic cholinergic nervous system blockade alters the anti-influenza immune response (2011) (0)
RiboPuromycylation Method (RPM): A New Technique for Visualizing Active Cellular Translation Sites and Exploring Translation Compartmentalization (2011) (0)
, Availability Quantity Control by Sensing Chaperone mTORC 1 Links Protein Quality and Protein Structure and Folding (2010) (0)
Cross-Priming in Induction of Vaccinia Contributions from Direct Priming and Proteins US 2 and US 11 Point to Inhibitory Effects of Cytomegalovirus (2002) (0)
Respiratory Syncytial Virus Predisposes Mice to Augmented Allergic Airway Responses Via IL-13-Mediated Mechanisms (2001) (0)
NeuraminidaseGenerated from Influenza A Virus Source of Antigenic Peptides Endogenously Defective Ribosomal Products Are the Major (2010) (0)
Correction: Efficient Cross-Priming of Antiviral CD8+ T Cells by Antigen Donor Cells Is GRP94 Independent (2010) (0)
INFLUENZA VIRUSES (ORTHOMYXOVIRIDAE) | Structure of Antigens (1999) (0)
IL-13-Mediated Mechanisms Viato Augmented Allergic Airway Responses Respiratory Syncytial Virus Predisposes Mice and Hussien (2001) (0)
Session 4: Initiation and potentiation of antiviral immunity (2007) (0)
Independent T Cells by Antigen Donor Cells + CD 8 Efficient Cross-Priming of Antiviral (2009) (0)
Drug Controlled Antigen Degradation Defines Sources of MHC Class I Peptides and Enables Pathway Discovery (130.29) (2010) (0)
Terminal Deoxynucleotidyl Transferase Establishes and Broadens Antiviral CD 8 T Cell Immunodominance Hierarchies 1 (2008) (0)
Making the Connection: Antibody Responsiveness and MHC Genes (2004) (0)
Influenza A Virus Hemagglutinin Trimerization Completes (2013) (0)
Editorial Board (2016) (0)
Synthesis?Translation in Defective Ribosomal Product Viral Protein Synthesis: A Role for Nuclear Antigenic Peptide Generation from Normal RNA Polymerase II Inhibitors Dissociate (2010) (0)
Virus Nucleoprotein Peptide Do Not Protect Mice (0)
Cytotoxic t cell recognition of influenza virus gene products (1985) (0)
Discovering protective T-cell responses by interrogating naturally processed antigenic determinants (2013) (0)
Is STAT6 Dependent During Respiratory Syncytial Virus Infection IL-13-Induced Airway Hyperreactivity (2001) (0)
Responsiveness and MHC Genes Making the Connection: Antibody (2010) (0)
Early dominance of irradiated host cells in the responder profiles of thymocytes from P. -->. F/sub 1/ radiation chimeras. [Mice; /sup 137/Cs] (1981) (0)
CORRECTIONS (1967) (0)
Emetine optimally facilitates nascent chain puromycylation and potentiates the ribopuromycylation method (RPM) applied to inert cells (2012) (0)
Exacerbates Influenza A Virus Pathogenesis Increases Proinflammatory Cytokines and Cutting Edge: Sympathetic Nervous System (2009) (0)
Endocytic Compartment to NKT Cells Endogenous Antigens Processed in an Recycling CD1d1 Molecules Present (2002) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Jack r. Bennink?

Jack r. Bennink is affiliated with the following schools:

Jack r. Bennink's Academic­Influence.com Rankings

Jack r. Bennink's Degrees

Why Is Jack r. Bennink Influential?

Jack r. Bennink's Published Works

Published Works

What Schools Are Affiliated With Jack r. Bennink?

Jack r. Bennink's AcademicInfluence.com Rankings